Health Records Reveal Sharp Rise in Gambling Diagnoses After Sports Betting Legalization
Researchers examined health records covering more than 197 million U.S. adults and discovered that diagnoses for problem gambling climbed more than 60 percent in states where sports betting has become legal, while those same diagnoses dropped 29 percent in states that kept the activity restricted, and this pattern emerged clearly in data released during June 2026.
The study tracked diagnosis rates before and after legalization measures took effect in various jurisdictions, and it isolated the impact of expanded access by comparing trends across state lines where policies diverged sharply. Observers note that overall diagnosis rates stayed low nationwide even after the increases, yet the proportional change stood out because it aligned directly with the rollout of legal sportsbooks in participating states.
Age Group Breakdown Shows Young Adults Hit Hardest
Adults aged 18 to 29 experienced the steepest climb, with diagnosis rates doubling in states that legalized sports betting, and this cohort accounted for a disproportionate share of the overall rise recorded in the records. Data shows younger adults encountered new betting platforms through mobile apps and retail locations, while older groups displayed smaller shifts in the same datasets.
Researchers compared pre-legalization baselines to post-legalization figures for each age bracket, and they found consistent patterns that held across multiple states rather than appearing in isolated markets. Those patterns suggest expanded availability coincided with higher identification of gambling-related issues, particularly among individuals who had not previously sought treatment.
State-by-State Comparisons Highlight Policy Differences
States that permitted sports betting saw the 60-plus percent jump in diagnoses, whereas states without legalization recorded the 29 percent decline over the same period, and this contrast allowed analysts to control for national trends that might otherwise obscure localized effects. The analysis drew from insurance claims and medical coding that captured formal diagnoses rather than self-reported behavior, which added precision to the measurements.
Figures reveal that the divergence widened as more states introduced legal frameworks between 2018 and 2025, and teh report ties the timing of increases to specific legalization dates in each jurisdiction. Experts have observed that states adopting similar tax and regulatory structures experienced comparable upticks, while those maintaining prohibitions continued their downward trajectory.
What's interesting is how the study accounted for population mobility and cross-border betting, yet the core signal remained tied to in-state legalization status, and researchers adjusted for demographic variables such as income and urban density to strengthen the comparison. The report underscores that expanded access correlates with increased issues even when overall prevalence stays modest relative to the adult population.
Report Details on Access and Identification Rates
The analysis points to greater visibility of gambling options through advertising and digital platforms as a factor that may prompt more individuals to recognize and report symptoms, and it notes that diagnosis rates can reflect both genuine incidence changes and improved detection. According to the full dataset, problem gambling codes appeared more frequently in medical encounters following legalization waves, while parallel codes for other behavioral health conditions did not show matching spikes in the same states.
Young adults in particular navigated new betting markets during a period of rapid smartphone adoption, and the doubled rates in that group prompted the authors to recommend targeted screening protocols in primary care settings. Observers note that low baseline rates mean even modest absolute increases can register as large percentage jumps, which is exactly what the records demonstrated across the 197-million-adult sample.
Conclusion
The June 2026 release of these findings supplies policymakers with a large-scale view of how legalization trajectories intersect with health outcomes, and the state-level contrasts offer a natural experiment that isolates policy effects from broader societal shifts. Researchers emphasize that continued monitoring will clarify whether the observed patterns stabilize or accelerate as markets mature, while the data already establishes a measurable link between expanded access and rising diagnosis counts in affected states.